Given this context, this review aims at collecting the available preclinical and clinical data on GRPR-targeting radiopeptides for the imaging and therapy of BC, focusing on the current state-of-the-art, future perspectives and possible limitations to their clinical translation. Here, GRPR is linked to breast cancer.